Medical treatment of endometriosis: is it a choice of the physician?

Ciprian Andrei Coroleucă; Diana-Elena Comandașu; Cătălin Bogdan Coroleucă; Mihai Mitran; Elvira Brătilă

doi:10.26416/gine.27.1.2020.2885

Medical treatment of endometriosis: is it a choice of the physician?

Ciprian Andrei Coroleucă, Diana-Elena Comandașu, Cătălin Bogdan Coroleucă, Mihai Mitran, Elvira Brătilă

In: Ginecologia.ro · 2020 · vol. 1(27) , pp. 20 · doi:10.26416/gine.27.1.2020.2885 · W3015175339

article OA: diamond CC0

🔓 Open OA copy View on OpenAlex View at publisher

⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-06 ⓘ

This review evaluated pharmaceutical options for endometriosis, finding that oral contraceptives and progestins effectively reduce recurrence rates after surgery.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Introduction. Endometriosis is a chronic benign pathology and the long-term management plan should include medical treatment and surgical procedures. The current treatment of endometriosis is based on surgery and ovarian suppressive agents. Materials and method. An analysis of the articles published in the specialty literature in order to evaluate the main pharmaceutical options used in the treatment of endometriosis and the recurrence rate of the disease. Results. Oral contraceptives, progestins, gonadotropin-releasing hormone agonists and antagonists, and aromatase inhibitors are the most commonly used agents in the treatment of endometriosis. Hormonal treatments are often associated with unwanted effects, such as delayed conception and recurrence of the disease and symptoms when stopped. The recurrence rate of endometriosis after the surgical treatment is almost 50%. The use of oral contraceptives and progestins was demonstrated to be effective in lowering the recurrence rate of endometriosis. Conclusions. Long-term medical therapy should be recommended for the treatment of endometriosis in order to control symptoms and to prevent recurrence after surgery. After first-line surgery, women should be informed of the high risk of endometriosis recurrence, and they should be invited to seek conception as soon as possible. An alternative is to inhibit ovulation until pregnancy is considered.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (39)

Source provenance

openalex: last seen: 2026-06-10T17:14:06.276822+00:00

License: CC0 · commercial use OK

[1] A levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot study via openalex

[2] Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis via openalex

[3] Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis via openalex

[4] Aromatase inhibitors: the next generation of therapeutics for endometriosis? via openalex

[5] Continuous versus cyclic oral contraceptives after laparoscopic excision of ovarian endometriomas: a systematic review and metaanalysis via openalex

[6] Dienogest compared with gonadotropin‐releasing hormone agonist after conservative surgery for endometriosis via openalex

[7] Emerging treatment of endometriosis via openalex

[8] Estrogen-progestins and progestins for the management of endometriosis via openalex

[9] Ethinylestradiol 20 μg/drospirenone 3 mg in a flexible extended regimen for the management of endometriosis-associated pelvic pain: a randomized controlled trial via openalex

[10] Histopathological analysis of laparoscopically treated ovarian endometriotic cysts with special reference to loss of follicles via openalex

[11] Hormonal therapy for endometriosis: from molecular research to bedside via openalex

[12] Hormonal treatment of patients with endometriosis in the postoperative phase via openalex

[13] Laparoscopic surgery for endometriosis: How often do we need to re-operate? via openalex

[14] Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial via openalex

[15] Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial via openalex

[16] Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial via openalex

[17] Lupron depot (leuprolide acetate for depot suspension) in the treatment of endometriosis: a randomized, placebo-controlled, double-blind study via openalex

[18] Maintenance therapy involving a tapering dose of danazol or mid/low doses of oral contraceptive after gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain via openalex

[19] Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain via openalex

[20] Medical Treatment in Endometriosis via openalex

[21] Medical treatment of endometriosis-related pain via openalex

[22] Medical Treatments for Endometriosis-Associated Pelvic Pain via openalex

[23] Pharmacological Treatment of Endometriosis via openalex

[24] Post-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidence via openalex

[25] Postoperative hormonal therapy after surgical excision of deep endometriosis via openalex

[26] Postoperative Medical Therapy After Surgical Treatment of Endometriosis: From Adjuvant Therapy to Tertiary Prevention via openalex

[27] Postoperative oral contraceptive exposure and risk of endometrioma recurrence via openalex

[28] Surgical versus low-dose progestin treatment for endometriosis-associated severe deep dyspareunia II: Effect on sexual functioning, psychological status and health-related quality of life via openalex

[29] Systematic review of the effects of aromatase inhibitors on pain associated with endometriosis via openalex

[30] Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain via openalex

[31] Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal endometriosis via openalex

[32] Use of GnRH antagonists in the treatment of endometriosis via openalex

[33] W2028726400 via openalex

[34] W2053998452 via openalex

[35] W1986492337 via openalex

[36] W2123134517 via openalex

[37] W1966091296 via openalex

[38] W4238358229 via openalex

[39] W4248493327 via openalex